0001017303 false 12/31 0001017303 2022-05-31 2022-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 31, 2022

 

 

TransAct Technologies Incorporated

(Exact name of registrant as specified in its charter)

 

 

Delaware 0-21121 06-1456680
(State or other jurisdiction of
incorporation)
(Commission file number) (I.R.S. employer identification no.)

 

One Hamden Center  
2319 Whitney Ave, Suite 3B, Hamden, CT 06518
(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number, including area code: (203) 859-6800

 

(Former Name or Former Address, if Changed Since Last Report): Not applicable.

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $.01 per share TACT NASDAQ Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging Growth Company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 

  
 

 

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

As described in Item 5.07 below, at the 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”) of TransAct Technologies Incorporated (the “Company”), the Company’s stockholders approved an amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to declassify the Company’s board of directors (the “Board”) over a three-year period beginning at the 2023 Annual Meeting of Stockholders. The Certificate of Amendment was previously approved by the Board, subject to approval by the Company’s stockholders, and became effective upon its filing with the Secretary of State of the State of Delaware (the “Delaware Secretary of State”) on May 31, 2022.

 

Prior to the effectiveness of the Certificate of Amendment, Article VII, Section 8 of the Certificate of Incorporation provided that the directors were classified, with respect to the time for which they hold office, into three classes, as nearly equal in number as possible, as determined by the Board, composed of directors each serving terms of office of three years. The Certificate of Amendment amends Section 8 to provide for the annual election of directors. Specifically, the Certificate of Amendment provides for the annual election of directors beginning at the 2023 Annual Meeting of Stockholders. Directors who have been elected to three-year terms prior to the effectiveness of the Certificate of Amendment, including directors elected at the 2022 Annual Meeting, will complete those three-year terms, and thereafter will be eligible for annual re-election after the completion of their current terms. Accordingly, directors who were elected at the 2021 Annual Meeting of Stockholders, whose terms will expire in 2024, and the directors who were elected at the 2022 Annual Meeting, whose terms will expire in 2025, will hold office until the end of their terms. From and including the 2025 Annual Meeting of Stockholders, the Board will be completely declassified and all directors will be subject to annual election to one-year terms.

 

In addition, until the Board is completely declassified, any director elected or appointed to the Board to fill a vacancy on the Board as a result of an increase in the size of the Board or due to the death, resignation, retirement, disqualification or removal of a director who was elected for a three-year term will continue to hold office until the next election of the class for which such director is chosen. In all cases, each director will hold office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal.

 

Under Delaware law, directors of a corporation that has a classified board of directors may be removed by stockholders only for cause, unless the certificate of incorporation of the corporation provides otherwise, while directors of a corporation that does not have a classified board of directors may be removed with or without cause. Accordingly, until the Board is completely declassified, the Company’s directors may be removed only for cause. Upon the completion of the declassification process in 2025, the Company’s directors will be removable with or without cause by an affirmative vote of the holders of a majority of the shares then entitled to vote on the election of directors.

 

Contingent upon stockholder approval of the Certificate of Amendment and effective upon the effectiveness of the Certificate of Amendment, the Board also approved amendments to the Company’s Amended and Restated By-laws (the “By-Laws”), including conforming changes to Article III, Section 3.02 of the By-Laws. The amendments to the By-Laws provide that a director appointed to fill a vacancy on the Board prior to the 2025 Annual Meeting of Stockholders will hold office for a term that will coincide with the remaining term of the class to which the director is appointed, and that a director appointed to fill a vacancy thereafter will be appointed to a term expiring at the next annual meeting of stockholders. The amendments to the By-Laws also include an amendment to Article III, Section 3.14, which previously provided that a director could be removed from office only for cause, to provide that (a) prior to the 2025 Annual Meeting of Stockholders, directors may be removed from office only for cause, and (b) from and including the 2025 Annual Meeting of Stockholders, directors may be removed from office with or without cause, in each case by the affirmative vote of holders of a majority of the voting power of all shares of the Company entitled to vote generally in the election of directors, voting together as a single class.

 

  
 

 

The amendments to the By-Laws also include the following changes:

 

·change of the title “chairman” of the Board to “chair” of the Board;

 

·deletion of Article V, Section 5.06, which included the role of “chairman” among the list of officers of the Company; and

 

·changes to Article VI to clarify that the Company may issue shares in certificated or uncertificated form.

 

The amendments to the By-Laws became effective upon the effectiveness of the Certificate of Amendment upon filing with the Delaware Secretary of State on May 31, 2022.

 

Copies of the Certificate of Amendment and the By-Laws (as amended) are filed as Exhibit 3.1 and Exhibit 3.2, respectively, to this Current Report on Form 8-K and are incorporated by reference herein. The foregoing descriptions of the Certificate of Amendment and the By-Laws do not purport to be complete and are qualified in their entirety by reference to the full text of the Certificate of Amendment and the By-Laws.

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

On May 31, 2022, at the 2022 Annual Meeting, the Company’s stockholders voted on the following proposals:

 

Proposal 1: Election of Directors

 

To elect Haydee Ortiz Olinger as director of the Company to serve until the 2025 Annual Meeting of Stockholders or until the director’s successor has been duly elected and qualified:

 

For    Withhold    Broker Non-Votes
5,887,965   279,127   1,981,046


To elect Emanuel P. N. Hilario as director of the Company to serve until the 2025 Annual Meeting of Stockholders or until the director’s successor has been duly elected and qualified:

 

For    Withhold    Broker Non-Votes
5,615,725   551,367   1,981,046

 

 

Proposal 2: Ratification of Independent Registered Public Accounting Firm

 

To ratify the selection of Marcum LLP as the Company’s independent registered public accounting firm for 2022:

 

For    Against    Abstain
8,135,139   3,498   9,501

 

  
 

 

Proposal 3: Advisory Vote on Executive Compensation

 

To approve, on an advisory basis, the Company’s compensation of its named executive officers:

 

For    Against    Abstain    Broker Non-Votes
4,972,262   1,129,490   65,340   1,981,046

 

 

Proposal 4: Amendment to the Certificate of Incorporation to Declassify the Board

 

To approve an amendment to the Company’s certificate of incorporation to declassify the Board of Directors of the Company:

 

For    Against    Abstain    Broker Non-Votes
6,144,485   15,830   6,777   1,981,046


On March 30, 2022, the Company entered into a Cooperation Agreement with 325 Capital Master Fund LP and Harbert Discovery Fund, LP, the terms of which are described in the Company’s Form 8-K filed with the U.S. Securities and Exchange Commission on March 31, 2022 (the “Cooperation Agreement Form 8-K”). The information required by Item 5.07(c) of Form 8-K is incorporated herein by reference to the disclosure set forth in Item 1.01 of the Cooperation Agreement Form 8-K.

 

Item 9.01Financial Statements and Exhibits.

 

(d)Exhibits

 

3.1   Certificate of Amendment to Certificate of Incorporation of TransAct Technologies Incorporated.
     
3.2   Amended and Restated By-Laws of TransAct Technologies Incorporated.
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

  
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

  TRANSACT TECHNOLOGIES INCORPORATED
     
  By: /s/ David B. Peters
    David B. Peters
    Vice President & Chief Accounting Officer

 

Date: June 2, 2022